- Ligand Pharmaceuticals (NASDAQ:LGND): Q3 EPS of $0.56 beats by $0.14.
- Revenue of $17.7M (+18.2% Y/Y) misses by $0.1M.
- Press Release
Ligand Pharmaceuticals beats by $0.14, misses on revenue
Recommended For You
More Trending News
About LGND Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| LGND | - | - |
| Ligand Pharmaceuticals Incorporated | ||